Drugs / DIT112
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06237231 | Feb → Mar 2025 overdue | — | EMS | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DIT112 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06237231 ↗ |
| Route | Oral | “1 tablet DIT112, oral;” NCT06237231 ↗ |